Crystal dPCR combines the unique benefits of sensitivity and accuracy with the multiplexing capacity of the three detection channels for the detection of multiple EGFR mutations in plasma cfDNA samples and corresponding CTCs of NSCLC patients. This evidence concerns the gene EGFR and non-small cell lung carcinoma.